Dr. Mohita Shrivastava: A Visionary Leader Transforming Cognitive Neuroscience and Brain Health

 


In a rapidly evolving world where cognitive resilience and mental agility are critical to personal and professional success, Dr. Mohita Shrivastava stands at the forefront of innovation in cognitive neuroscience and neuropsychology. An internationally trained neuroscientist and an influential thought leader, Dr. Shrivastava is the Founder, Director, and Chief Executive Officer of Cognitome LLC, headquartered in the United Arab Emirates. Through her pioneering work, she is redefining how cognitive health is understood, trained, and rehabilitated on a global scale.

Academic Excellence and Global Training

Dr. Shrivastava’s professional journey is built upon a strong foundation of academic excellence and international research exposure. She earned her Doctorate (Ph.D.) in Neurosciences from the All India Institute of Medical Sciences (AIIMS), New Delhi, one of the most prestigious medical and research institutions in the region. Her doctoral work was further strengthened through advanced research training at the Kansas University Medical Center, USA, where she engaged with cutting-edge neuroscience research and interdisciplinary clinical models.

To complement her neuroscientific expertise, Dr. Shrivastava completed an Advanced Postgraduate Diploma in Applied Neuropsychology from the University of Bristol, United Kingdom. This rare combination of neuroscience research and applied neuropsychology enables her to translate complex brain science into practical, evidence-based cognitive interventions—bridging the gap between theory and real-world application.

Over 15 Years of Multidisciplinary Impact

With more than 15 years of experience across neuroscience research, higher education, clinical therapeutics, and community outreach, Dr. Shrivastava has cultivated a career that reflects depth, versatility, and sustained impact. Her work spans cognitive development, brain-behavior relationships, neuroplasticity, mental health, and cognitive rehabilitation across diverse populations.

As an educator and mentor, she has contributed significantly to training future professionals in neuroscience and psychology, emphasizing scientific integrity, innovation, and ethical practice. Her teaching and mentorship have helped foster a new generation of professionals equipped to address complex cognitive and mental health challenges.

Cognitome LLC: Redefining Cognitive Rehabilitation

As the Founder and CEO of Cognitome LLC, Dr. Shrivastava has introduced a transformative approach to cognitive health through the Cognitome Program—a next-generation cognitive rehabilitation and brain training framework grounded in neuroscience and neuropsychology.

The Cognitome Program is designed around the principle that the brain is inherently adaptive. By leveraging neuroplasticity and employing a multimodal cognitive training framework, the program addresses cognitive, emotional, and functional domains in an integrated manner. This holistic approach ensures that interventions are personalized, outcome-driven, and applicable to real-world cognitive demands.

Recognized globally for its innovation and impact, the Cognitome Program serves individuals across clinical, educational, and performance-oriented settings, offering scalable solutions for cognitive rehabilitation, enhancement, and long-term brain health.

Workshop Highlight: Remapping the Brain and Orchestrating Cognition

A key extension of Dr. Shrivastava’s thought leadership is her workshop titled:

“Remapping the Brain & Orchestrating Cognition: A Workshop on Next-Gen Cognitive Rehabilitation through the Cognitome Program’s Multimodal Training Framework.”

This advanced workshop presents a comprehensive exploration of contemporary cognitive rehabilitation, moving beyond traditional compartmentalized models toward an integrated, systems-based understanding of cognition. Participants gain insights into the science of neuroplasticity, the orchestration of cognitive domains, and the application of multimodal training strategies for sustainable cognitive outcomes.

The workshop is designed for clinicians, researchers, educators, and mental health professionals seeking evidence-based, future-ready approaches to cognitive rehabilitation and brain performance optimization.

Leadership, Advocacy, and Scholarly Contribution

Dr. Shrivastava is an active member of leading international neuroscience organizations and serves on the editorial boards of reputed scientific journals, contributing to the advancement of research quality and academic discourse in neuroscience and neuropsychology.

Beyond academia, she is a respected voice in mental health advocacy. As a regular columnist for Khaleej Times and Passion Vista Global Magazine, she translates complex neuroscientific concepts into accessible, impactful narratives, fostering public awareness around cognitive wellness, emotional resilience, and mental health literacy.

Her ability to engage both scientific and general audiences underscores her commitment to making brain science relevant, inclusive, and actionable.

Awards and Global Recognition

Dr. Mohita Shrivastava’s contributions have been recognized through numerous prestigious international honors, including:

  • Top Neuroscientist of the Year 2024 – IAOTP

  • Outstanding Leadership Award 2023

  • Visionaries Award 2024

  • Global Mental Health Advocacy Leadership Award 2024

In addition, the Cognitome Program received the distinction of Top Global Cognitive Health and Rehabilitation Program of the Year 2025 (IAOTP), affirming its excellence, innovation, and global relevance in cognitive care.

Commitment to Cognitive Wellness and Resilience

Central to Dr. Shrivastava’s professional ethos is her guiding principle:

“An active brain is the cornerstone of a vibrant existence, and cognitive wellness is the foundation of resilience.”

This philosophy informs her research, leadership, and program development, emphasizing proactive cognitive care and lifelong brain health. Her work advocates for early intervention, continuous cognitive engagement, and personalized strategies to enhance mental adaptability in an increasingly complex world.

Global Engagement and Conference Participation

As part of her ongoing global engagement, Dr. Mohita Shrivastava will be attending the neuroscience conference as a workshop presenter, where she will share her expertise on next-generation cognitive rehabilitation and the Cognitome Program’s multimodal framework. Her participation highlights her role as a trusted authority and contributor to international neuroscience discourse.

Conclusion

Dr. Mohita Shrivastava exemplifies excellence in cognitive neuroscience, visionary leadership, and innovation-driven entrepreneurship. Through Cognitome LLC and her extensive professional endeavors, she continues to shape the future of cognitive rehabilitation and brain health worldwide. Her work stands as a testament to the transformative power of neuroscience when guided by purpose, precision, and a deep commitment to human well-being.

#DrMohitaShrivastava #CognitomeProgram #CognitiveNeuroscience #Neuropsychology #CognitiveRehabilitation #BrainHealth #Neuroplasticity #MentalWellness #NeuroscienceLeadership #CognitiveTraining #GlobalNeuroscience #BrainResilience #MentalHealthAdvocacy #NeuroInnovation #CognitiveWellbeing

Comments

Post a Comment

Popular posts from this blog

Exhibitor Opportunities Closing Soon: Be a Part of the 5th World Neuroscience Summit and Showcase Your Innovations to a Global Audience

 The 5th World Neuroscience, Neurology & Brain Disorders Summit (NeuroscienceUCG 2026) , taking place from January 14–16, 2026, at Novotel Al Barsha, Dubai, UAE , is now accepting final exhibitor registrations. With only a few slots remaining , this is your opportunity to showcase your organization’s cutting-edge products, technologies, and services to a truly global audience of neuroscience professionals, researchers, and innovators. As one of the most anticipated international gatherings in the neuroscience community, NeuroscienceUCG 2026 serves as a platform where science, technology, and collaboration converge. Exhibitors gain an unparalleled opportunity to connect directly with influential leaders shaping the future of neurology, brain research, and clinical innovation. Why Exhibit at NeuroscienceUCG 2026 Global Brand Exposure Display your products to an international audience of neurologists, neurosurgeons, neuroscientists, and healthcare professionals from over 10...
Read more

Showcase Innovation: Limited Exhibitor Slots Available at the 5th World Neuroscience Conference 2026

 The 5th World Neuroscience, Neurology & Brain Disorders Summit (NeuroscienceUCG 2026) , taking place from January 14–16, 2026 , in Dubai, UAE , is now inviting leading organizations, innovators, and research institutions to participate as exhibitors . With only a few exhibition slots remaining, this is your opportunity to present your latest products, technologies, and solutions to a global audience shaping the future of neuroscience and neurology . This prestigious international conference serves as a dynamic platform for collaboration, discovery, and innovation , bringing together clinicians, researchers, academicians, entrepreneurs, and industry professionals from over 100 countries . Exhibiting at NeuroscienceUCG 2026 offers a unique opportunity to engage directly with decision-makers , expand your professional network , and enhance your organization’s visibility in the rapidly advancing field of neuroscience. Why Secure an Exhibitor Slot at NeuroscienceUCG 202...
Read more

Innovate, Inspire, and Showcase — Exhibitor Opportunities at NeuroscienceUCG 2026

 The 5th World Neuroscience, Neurology & Brain Disorders Summit (NeuroscienceUCG 2026) , scheduled for January 14–16, 2026, in Dubai, UAE , welcomes global exhibitors to present their innovations, technologies, and solutions that are transforming the future of neuroscience and brain health. This premier international platform brings together industry pioneers, researchers, clinicians, and academic leaders to exchange ideas, foster collaborations, and accelerate advancements in neuroscience and neurology. Exhibitor Categories & Product Types for Showcase 1. Neurotechnology & Medical Devices Showcase groundbreaking innovations in: EEG, MEG, and MRI systems Deep Brain Stimulation (DBS) and neuromodulation tools Brain-mapping and neuro-navigation systems Intraoperative monitoring and surgical guidance solutions 2. Pharmaceuticals & Biotechnology Highlight research and development in: Neurodegenerative and psychiatric disorder therapies Neuro...
Read more